Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20250406065235N1Phase 3Completed
Phase 3 trial of curcumin in female sexual dysfunction (FSD) and sexual dysfunction, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Sexual function improvement. Started Apr 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20250406065235N1.